Cerebral Palsy Clinical Trial
— Purple-NOfficial title:
A Multi-country, Multi-centre, Observational, Cross-sectional Study to Evaluate Individualized Treatment and Management in Children and Adolescents With Cerebral Palsy
NCT number | NCT03499288 |
Other study ID # | MPR15FA89628 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 11, 2017 |
Est. completion date | July 3, 2018 |
Verified date | November 2018 |
Source | Nutricia Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
HCPs will complete questionnaires about their patients with Cerebral Palsy (CP) and invite parents/caregivers of these patients to fill in questionnaires as well. Questionnaires include questions on individualized treatment, nutritional profile and management, and patient characteristics.
Status | Completed |
Enrollment | 499 |
Est. completion date | July 3, 2018 |
Est. primary completion date | July 3, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Month to 17 Years |
Eligibility |
Inclusion Criteria: 1. Confirmed diagnosis of Cerebral Palsy 2. Age<18 years 3. Have visited the HCP within the last year 4. Written informed consent provided by parents/legal representatives according to local law Exclusion Criteria: 1. Neurodegenerative diseases 2. Acute infections: meningitis, encephalitis or poliomyelitis |
Country | Name | City | State |
---|---|---|---|
Czechia | Fakultní nemocnice v Motole | Praha | |
Greece | Attikon University General Hospital | Athens | |
Hungary | Bethesda Children Hospital Budapest | Budapest | |
Italy | AO Sant'Orsola - Malpighi, Policlinico | Bologna | |
Italy | ASST degli Spedali Civili di Brescia | Brescia | |
Italy | Fondazione IRCCS Istituto Neurologico "Carlo Besta" | Milano | |
Italy | AOU di Modena - Policlinico | Modena | |
Netherlands | Roessingh centrum voor Revalidatie | Enschede | |
Poland | Medical university hospital of Gdansk | Gdansk | |
Poland | Szpital Kliniczny im. Heliodora Swiecickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu | Poznan | |
Slovakia | Fakultná nemocnica Trnava | Trnava | |
Turkey | Ankara University School of Medicine/Neurology | Ankara | |
Turkey | Gazi University School of Medicine/Neurology | Ankara | |
Turkey | Hacettepe University School of Medicine/Neurology | Ankara | |
Turkey | Ege University School of Medicine/Neurology | Ege | |
Turkey | Eskisehir Osmangazi University School of Medicine/Neurology | Eskisehir | |
Turkey | Inonu University School of Medicine/Neurology | Inönü | |
Turkey | Dokuz Eylul University School of Medicine/Neurology | Izmir | |
Turkey | Marmara University School of Medicine/Neurology | Marmara | |
Turkey | Mersin University School of Medicine/Neurology | Mersin |
Lead Sponsor | Collaborator |
---|---|
Nutricia Research |
Czechia, Greece, Hungary, Italy, Netherlands, Poland, Slovakia, Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Quality of life and participation 1 | Questionnaire to assess Quality of Life of subjects with CP [scores on domains] | Data collected retrospectively, from within 12 months of entering the questionnaire | |
Other | Quality of life and participation 2 | Questionnaire to assess Quality of Life of parents (/legal representatives) of subjects with CP [scores on domains] | Data collected retrospectively, from within 12 months of entering the questionnaire | |
Other | Quality of life and participation 3 | Level of participation included in the general parent questionnaire [categories] | Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 1 (general subject characteristics): | Using questionnaires to quantify current CP characteristics with respect to: - General subject characteristics (e.g. Sex, Birth weight [g], Type of CP motor disorder [category] |
Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 2 (anthropometry): | Using questionnaires to quantify current CP characteristics with respect to: Anthropometry: length [cm]; weight [grams] and BMI (kg/m2) |
Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 3 (motor function) | Using questionnaires to quantify current CP characteristics with respect to: Motor function (GMFCS [category]; GMFM measurement type [GMFM-86/GMFM-88] |
Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 4 (comorbidities) | Using questionnaires to quantify current CP characteristics with respect to: Comorbidities: epilepsy, cognitive function, GI problems [categories] |
Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 5 (therapies) | Using questionnaires to quantify current CP characteristics with respect to: Type and frequency of physical/occupational therapy [type, number of hours per day /days per week] |
Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 6 (feeding mode) | Using questionnaires to quantify current CP characteristics with respect to: Feeding mode and/or problems (tube feeding [yes/no], type of tube feeding etc) |
Data collected retrospectively, from within 12 months of entering the questionnaire | |
Primary | Quantify current CP characteristics 7 (nutritional status) | Using questionnaires to quantify current CP characteristics with respect to: Nutritional status (HCP and parent perspective on nutritional status, concerns [yes/no]) |
Data collected retrospectively, from within 12 months of entering the questionnaire |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05317234 -
Genetic Predisposition in Cerebral Palsy
|
N/A | |
Recruiting |
NCT05576948 -
Natural History of Cerebral Palsy Prospective Study
|
||
Completed |
NCT04119063 -
Evaluating Wearable Robotic Assistance on Gait
|
Early Phase 1 | |
Completed |
NCT03264339 -
The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy
|
N/A | |
Completed |
NCT05551364 -
Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy
|
N/A | |
Completed |
NCT03902886 -
Independent Walking Onset of Children With Cerebral Palsy
|
||
Recruiting |
NCT05571033 -
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
|
N/A | |
Not yet recruiting |
NCT04081675 -
Compliance in Children With Cerebral Palsy Supplied With AFOs
|
||
Completed |
NCT02167022 -
Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
|
N/A | |
Completed |
NCT04012125 -
The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy
|
N/A | |
Enrolling by invitation |
NCT05619211 -
Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities
|
Phase 1 | |
Completed |
NCT04489498 -
Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
|
||
Completed |
NCT03677193 -
Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy
|
N/A | |
Recruiting |
NCT06450158 -
Robot-assisted Training in Children With CP
|
N/A | |
Completed |
NCT04093180 -
Intensive Neurorehabilitation for Cerebral Palsy
|
N/A | |
Completed |
NCT02909127 -
The Pediatric Eating Assessment Tool
|
||
Not yet recruiting |
NCT06377982 -
Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy
|
Phase 1 | |
Not yet recruiting |
NCT06007885 -
Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention.
|
N/A | |
Not yet recruiting |
NCT03183427 -
Corpus Callosum Size in Patients With Pineal Cyst
|
N/A | |
Active, not recruiting |
NCT03078621 -
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
|
Phase 1/Phase 2 |